Long-term effect of pulmonary rehabilitation in idiopathic pulmonary fibrosis: a randomised controlled trial
暂无分享,去创建一个
S. Fuke | M. Ando | R. Kozu | Y. Kondoh | O. Nishiyama | H. Sasano | K. Kataoka | T. Ogawa | F. Watanabe | K. Nishimura | T. Ogura | H. Hasegawa | Yoshihiro Mori | K. Ichikado | H. Ishimoto | H. Tomioka | O. Hataji | Hiroyuki Ito | Hideo Saka | Yasuhiro Goto | M. Arita | R. Shintani | S. Miyazaki | K. Tomii | T. Tsuda | S. Arizono | Masashi Shiraishi | S. Eda | Takuma Sasaki | M. Kagajo | Koji Sakamoto
[1] C. Malaguti,et al. Supervised maintenance programmes following pulmonary rehabilitation compared to usual care for chronic obstructive pulmonary disease. , 2021, The Cochrane database of systematic reviews.
[2] M. Ando,et al. Protocol for long-term effect of pulmonary rehabilitation under nintedanib in idiopathic pulmonary fibrosis , 2021, ERJ Open Research.
[3] A. Prasse,et al. Short-Term Effects of Comprehensive Pulmonary Rehabilitation and its Maintenance in Patients with Idiopathic Pulmonary Fibrosis: A Randomized Controlled Trial , 2020, Journal of clinical medicine.
[4] L. Richeldi,et al. Current and Future Idiopathic Pulmonary Fibrosis Therapy , 2019, The American journal of the medical sciences.
[5] W. Janssens,et al. Short and long-term effects of pulmonary rehabilitation in interstitial lung diseases: a randomised controlled trial , 2018, Respiratory Research.
[6] Takeshi Johkoh,et al. Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline , 2018, American journal of respiratory and critical care medicine.
[7] O. Nishiyama,et al. Physical activity in daily life in patients with idiopathic pulmonary fibrosis. , 2018, Respiratory investigation.
[8] A. Sheel,et al. Effects of hyperoxia on dyspnoea and exercise endurance in fibrotic interstitial lung disease , 2017, European Respiratory Journal.
[9] M. Ando,et al. COPD Assessment Test for measurement of health status in patients with idiopathic pulmonary fibrosis: A cross‐sectional study , 2017, Respirology.
[10] A. Holland,et al. The evidence of benefits of exercise training in interstitial lung disease: a randomised controlled trial , 2017, Thorax.
[11] F. Maltais,et al. High Oxygen Delivery to Preserve Exercise Capacity in Patients with Idiopathic Pulmonary Fibrosis Treated with Nintedanib. Methodology of the HOPE-IPF Study. , 2016, Annals of the American Thoracic Society.
[12] Mariko Carey,et al. Interventions to aid patient adherence to physiotherapist prescribed self-management strategies: a systematic review. , 2016, Physiotherapy.
[13] G. Raghu,et al. Drug Treatment of Idiopathic Pulmonary Fibrosis: Systematic Review and Network Meta-Analysis. , 2016, Chest.
[14] José Oliveira,et al. Long-Term Effects of a 12-Week Exercise Training Program on Clinical Outcomes in Idiopathic Pulmonary Fibrosis , 2015, Lung.
[15] A. Azuma,et al. A Phase 3 Trial of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis , 2015 .
[16] Efficacy and Safety of Nintedanib in Idiopathic Pulmonary Fibrosis. , 2015, The New England journal of medicine.
[17] R. Kozu,et al. Endurance Time Is the Most Responsive Exercise Measurement in Idiopathic Pulmonary Fibrosis , 2014, Respiratory Care.
[18] Sally J. Singh,et al. British Thoracic Society guideline on pulmonary rehabilitation in adults: accredited by NICE , 2013, Thorax.
[19] R. Tachikawa,et al. Evaluation of the chronic obstructive pulmonary disease assessment test for measurement of health‐related quality of life in patients with interstitial lung disease , 2012, Respirology.
[20] Takeshi Johkoh,et al. American Thoracic Society Documents An Official ATS / ERS / JRS / ALAT Statement : Idiopathic Pulmonary Fibrosis : Evidence-based Guidelines for Diagnosis and Management , 2011 .
[21] H. Collard,et al. Pulmonary rehabilitation for interstitial lung disease. , 2010, Chest.
[22] Y. Kondoh,et al. A simple assessment of dyspnoea as a prognostic indicator in idiopathic pulmonary fibrosis , 2010, European Respiratory Journal.
[23] P. Jones,et al. Quantification of dyspnoea using descriptors: development and initial testing of the Dyspnoea-12 , 2009, Thorax.
[24] P. Jones,et al. Development and first validation of the COPD Assessment Test , 2009, European Respiratory Journal.
[25] Y. Kondoh,et al. Effects of pulmonary rehabilitation in patients with idiopathic pulmonary fibrosis , 2008, Respirology.
[26] Basia Belza,et al. A randomized clinical trial of an activity and exercise adherence intervention in chronic pulmonary disease. , 2008, Archives of physical medicine and rehabilitation.
[27] A. Holland,et al. Short term improvement in exercise capacity and symptoms following exercise training in interstitial lung disease , 2008, Thorax.
[28] Y. Kondoh,et al. Quadriceps weakness is related to exercise capacity in idiopathic pulmonary fibrosis. , 2005, Chest.
[29] Y. Kondoh,et al. Health-related quality of life in patients with idiopathic pulmonary fibrosis. What is the main contributing factor? , 2005, Respiratory medicine.
[30] P. Jones,et al. A self-complete measure of health status for chronic airflow limitation. The St. George's Respiratory Questionnaire. , 1992, The American review of respiratory disease.
[31] R. Snaith,et al. The Hospital Anxiety And Depression Scale , 2003, Health and quality of life outcomes.
[32] J. A. Daubenspeck,et al. Comparison of clinical dyspnea ratings and psychophysical measurements of respiratory sensation in obstructive airway disease. , 2015, The American review of respiratory disease.
[33] C. Wells,et al. The measurement of dyspnea. Contents, interobserver agreement, and physiologic correlates of two new clinical indexes. , 1984, Chest.